Latest & greatest articles for osteoarthritis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on osteoarthritis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on osteoarthritis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for osteoarthritis

481. Intra-articular viscosupplementation with hylan G-F 20 to treat osteoarthritis of the knee: an evidence-based analysis

of this assessment has been made for the HTA database. Citation Intra-articular viscosupplementation with hylan G-F 20 to treat osteoarthritis of the knee: an evidence-based analysis. Medical Advisory Secretariat (MAS). Volume 5(10). 2005 Authors' objectives The aim of this review was to assess the effectiveness and cost-effectiveness of hylan G-F 20 as a substitute for existing treatments for pain due to osteoarthritis (OA) of the knee, other viscosupplementation devices, and/or as an adjunct to conventional (...) considerable methodological limitations that result in uncertainty about the magnitude of effect. An upcoming review of the evidence by the Osteoarthritis Advisory Panel of clinical experts will likely help to reduce some of this uncertainty. There is moderate evidence that hylan G-F 20 is no more clinically effective than NSAIDs. The evidence that hylan G-F 20 may be an appropriate option for people with OA of the knee who cannot tolerate NSAIDs is indirect. The possible benefit of fewer cases of NSAID

2005 Health Technology Assessment (HTA) Database.

482. Randomised controlled trial of the cost-effectiveness of water-based therapy for lower limb osteoarthritis

of the quality of this assessment has been made for the HTA database. Citation Cochrane T, Davey R C, Matthes Edwards S M. Randomised controlled trial of the cost-effectiveness of water-based therapy for lower limb osteoarthritis. Health Technology Assessment 2005; 9(31): 1 -130 Authors' objectives The aim of this report was to determine the efficacy of community water-based therapy for the management of lower limb osteoarthritis (OA) in older patients. Authors' conclusions Group-based exercise in water over (...) , from both a provider and a participant perspective, the societal costs of the different approaches to the management of OA and longer term trends in outcome measures (costs and effects). Project page URL INAHTA brief and checklist Indexing Status Subject indexing assigned by CRD MeSH Exercise Therapy; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Water Language Published English Country of organisation England Address for correspondence NETSCC, Health Technology Assessment, Alpha House

2005 Health Technology Assessment (HTA) Database.

483. Unicompartmental knee arthroplasty for unicompartmental osteoarthritis: a systematic review. Report no 44.

surrounding the treatment of osteoarthritis in the knee. The continuing contribution of data to national joint registries will aid in validating the current trends, particularly in knee survival after unicompartmental or total knee arthroplasty. Project page URL INAHTA brief and checklist Indexing Status Subject indexing assigned by CRD MeSH Arthroplasty, Replacement, Knee /methods; Osteoarthritis, Knee /surgery Language Published English Country of organisation Australia Address for correspondence PO Box (...) Unicompartmental knee arthroplasty for unicompartmental osteoarthritis: a systematic review. Report no 44. Unicompartmental knee arthroplasty for unicompartmental osteoarthritis: a systematic review. Report no 44. Unicompartmental knee arthroplasty for unicompartmental osteoarthritis: a systematic review. Report no 44. Australian Safety and Efficacy Register of New Interventional Procedures - Surgical Record Status This is a bibliographic record of a published health technology assessment from

2005 Health Technology Assessment (HTA) Database.

484. Celecoxib for the treatment of pain in osteoarthritis and rheumatoid arthritis

. Celecoxib for the treatment of pain in osteoarthritis and rheumatoid arthritis. Edmonton: Alberta Heritage Foundation for Medical Research (AHFMR). AHFMR - Information Paper #24. 2005 Authors' objectives The objective of this review was to present the current evidence on the efficacy/effectiveness and safety of celecoxib (Celebrex (R)) for the treatment of pain in patients with osteoarthritis (OA) and rheumatoid arthritis (RA). Authors' conclusions Overall, short-term use of celecoxib was equivalent (...) Celecoxib for the treatment of pain in osteoarthritis and rheumatoid arthritis Celecoxib for the treatment of pain in osteoarthritis and rheumatoid arthritis Celecoxib for the treatment of pain in osteoarthritis and rheumatoid arthritis Moga C, Harstall C, Tang Z Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Moga C, Harstall C, Tang Z

2005 Health Technology Assessment (HTA) Database.

485. Artificial trapeziometacarpal joint replacement for end-stage osteoarthritis

Artificial trapeziometacarpal joint replacement for end-stage osteoarthritis Artificial trapeziometacarpal joint replacement for end-stage osteoarthritis Artificial trapeziometacarpal joint replacement for end-stage osteoarthritis National Institute for Clinical Excellence Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation National Institute for Clinical Excellence (...) . Artificial trapeziometacarpal joint replacement for end-stage osteoarthritis. London: National Institute for Clinical Excellence (NICE) 2005: 2 Authors' objectives This study aims to assess the current evidence on artificial trapeziometacarpal joint replacement for end-stage osteoarthritis. Authors' conclusions 1.1 Current evidence on the safety and efficacy of artificial trapeziometacarpal (TMC) joint replacement for end-stage osteoarthritis appears adequate to support the use of this procedure provided

2005 Health Technology Assessment (HTA) Database.

486. Special report: intra-articular hyaluronan for osteoarthritis of the knee

Special report: intra-articular hyaluronan for osteoarthritis of the knee Special report: intra-articular hyaluronan for osteoarthritis of the knee Special report: intra-articular hyaluronan for osteoarthritis of the knee BlueCross BlueShield Association Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. The BlueCross BlueShield Association Technology Evaluation Center (...) website ( ) includes the most recent 3 years of TEC Assessments. To request older reports, please use the “contact us” feature on the website. Citation BlueCross BlueShield Association. Special report: intra-articular hyaluronan for osteoarthritis of the knee. Chicago: BlueCross BlueShield Association (BCBS). TEC Assessment 19(17). 2005 Authors' objectives The purpose of this Special Report is to review the evidence on hyaluronan from the perspective of the prior TEC Assessment (1998) and the 3

2005 Health Technology Assessment (HTA) Database.

487. Pulsed electromagnetic field therapy and osteoarthritis of the knee: synthesis of the literature

of the individual trial results was provided and the difference between the intervention and control group was not clearly reported for all trials. This means that it is not possible to properly assess the conclusions. Authors' objectives To describe the results of efficacy studies on the application of therapeutic pulsed electromagnetic fields to patients with varying severity of knee joint osteoarthritis. Searching MEDLINE (1966 to 2005), EMBASE (1982 to 2005), AMED (1996 to 2005), and CINAHL (1966 to 2005 (...) ) databases were searched for articles in English. Study selection Randomised controlled trials (RCTs) assessing the effectiveness of the application of pulsed electromagnetic fields to knee joints with osteoarthritis were included in this review. The intervention characteristics varied widely across trials; session duration ranged from six minutes to one hour, the number of sessions ranged from eight to 84, and the frequency of administration ranged from three times daily to three-to-five times per week

2005 DARE.

488. Aerobic walking or strengthening exercise for osteoarthritis of the knee: a systematic review

Aerobic walking or strengthening exercise for osteoarthritis of the knee: a systematic review Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 DARE.

489. Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis

Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 DARE.

490. Glucosamine long-term treatment and the progression of knee osteoarthritis: systematic review of randomized controlled trials

Glucosamine long-term treatment and the progression of knee osteoarthritis: systematic review of randomized controlled trials Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 DARE.

491. Systematic review of therapies for osteoarthritis of the hand

Systematic review of therapies for osteoarthritis of the hand Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 DARE.

492. Pathogenesis and management of pain in osteoarthritis. (Abstract)

Pathogenesis and management of pain in osteoarthritis. The term osteoarthritis describes a common, age-related, heterogeneous group of disorders characterised pathologically by focal areas of loss of articular cartilage in synovial joints, associated with varying degrees of osteophyte formation, subchondral bone change, and synovitis. Joint damage is caused by a mixture of systemic factors that predispose to the disease, and local mechanical factors that dictate its distribution and severity (...) . Various genetic abnormalities have been described, but most sporadic osteoarthritis probably depends on minor contributions from several genetic loci. Osteoarthritic joint damage may be associated with clinical problems, but the severity of joint disease is only weakly related to that of the clinical problem. For this reason the associations and pathogenesis of pain are in as much need of investigation as joint damage. Subchondral bone and synovium may be responsible for nociceptive stimuli

2005 Lancet

493. A topical cream containing glucosamine and chondroitin sulphate reduced joint pain in osteoarthritis of the knee Full Text available with Trip Pro

A topical cream containing glucosamine and chondroitin sulphate reduced joint pain in osteoarthritis of the knee A topical cream containing glucosamine and chondroitin sulphate reduced joint pain in osteoarthritis of the knee | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here A topical cream containing glucosamine and chondroitin sulphate reduced joint pain in osteoarthritis of the knee Article Text Therapeutics A topical cream containing

2004 Evidence-Based Medicine

494. Mobile bearing vs fixed bearing prostheses for total knee arthroplasty for post-operative functional status in patients with osteoarthritis and rheumatoid arthritis. (Abstract)

Mobile bearing vs fixed bearing prostheses for total knee arthroplasty for post-operative functional status in patients with osteoarthritis and rheumatoid arthritis. The polyethylene insert in a total knee replacement (TKR) can be fixed to the tibial plateau or it can have freedom of rotation and / or translation. It is not yet clear whether there are differences in functional or clinical results between the two prosthesis types.The goal of this review is to assess if a mobile bearing total (...) knee prosthesis provides a better range of motion (ROM) and a better functional outcome than a fixed bearing prosthesis in patients with rheumatoid arthritis or osteoarthritis after total knee arthroplasty.We searched the Cochrane Library (issue 2002-3), Current contents (1996 to September 2002), and MEDLINE (1966 to September 2002). Reference lists of selected articles were also included.Randomised controlled trials or controlled clinical trials were selected which used a functional or clinical

2004 Cochrane

495. Low level laser therapy (Classes I, II and III) for treating osteoarthritis. (Abstract)

Low level laser therapy (Classes I, II and III) for treating osteoarthritis. Osteoarthritis (OA) affects a large proportion of the population. Low Level Laser Therapy (LLLT) is a light source that generates extremely pure light, of a single wavelength. The effect is not thermal, but rather related to photochemical reactions in the cells. LLLT was introduced as an alternative non-invasive treatment for OA about 20 years ago, but its effectiveness is still controversial.To assess (...) . Despite some positive findings, this meta-analysis lacked data on how LLLT effectiveness is affected by four important factors: wavelength, treatment duration of LLLT, dosage and site of application over nerves instead of joints. There is clearly a need to investigate the effects of these factors on LLLT effectiveness for OA in randomized controlled clinical trials.

2004 Cochrane

496. Glucosamine: review of its effectiveness in treating knee osteoarthritis

effectiveness in treating knee osteoarthritis. Richmond, BC: WorkSafe BC 2004: 23 Authors' objectives This study provides a review of the effectiveness of glucosamine in treating knee osteoarthritis (OA). Authors' conclusions There is some level 1 evidence on the short and long term effectiveness of glucosamine in alleviating OA symptoms, as measured by pain index, Lequesne index or WOMAC, particularly of the hip or knee joint. There is also some level 1 evidence on the possible role of glucosamine (...) as a structure-modifying drug for OA as measured by x-ray imaging of the joint space. The majority of research regarding glucosamine and OA were undertaken on patients with either knee or hip OA. This limitation raises questions regarding the generalizability of the outcome toward OA of other joints such as those in the hand/wrist, shoulder and ankle. The majority of clinical studies were done with glucosamine sulphate and little evidence is available on the efficacy of other forms of glucosamine (e.g

2004 Health Technology Assessment (HTA) Database.

497. Effectiveness of physical therapy, restricted to electrotherapy and exercise, for osteoarthritis of the knee

Effectiveness of physical therapy, restricted to electrotherapy and exercise, for osteoarthritis of the knee Effectiveness of physical therapy, restricted to electrotherapy and exercise, for osteoarthritis of the knee Effectiveness of physical therapy, restricted to electrotherapy and exercise, for osteoarthritis of the knee The Norwegian Knowledge Centre for the Health Services Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA (...) . No evaluation of the quality of this assessment has been made for the HTA database. Citation The Norwegian Knowledge Centre for the Health Services. Effectiveness of physical therapy, restricted to electrotherapy and exercise, for osteoarthritis of the knee. Oslo: The Norwegian Knowledge Centre for the Health Services (NOKC) 2004: 104 Authors' objectives The aim of this report was to evaluate the effectiveness of physical therapy, restricted to electrotherapy and exercise, for osteoarthritis of the knee

2004 Health Technology Assessment (HTA) Database.

498. Supplementation of a home-based exercise programme with a class-based programme for people with osteoarthritis of the knees: a randomised controlled trial and health economic analysis

Supplementation of a home-based exercise programme with a class-based programme for people with osteoarthritis of the knees: a randomised controlled trial and health economic analysis Supplementation of a home-based exercise programme with a class-based programme for people with osteoarthritis of the knees: a randomised controlled trial and health economic analysis Supplementation of a home-based exercise programme with a class-based programme for people with osteoarthritis of the knees (...) for people with osteoarthritis of the knees: a randomised controlled trial and health economic analysis. Health Technology Assessment 2004; 8(46): 1-76 Authors' objectives The study aimed to establish the relative effectiveness and cost of providing a home-based exercise programme versus home-based exercise supplemented with an 8-week class-based exercise programme. Authors' conclusions The supplementation of a home-based exercise programme with a class-based exercise programme led to superior

2004 Health Technology Assessment (HTA) Database.

499. Acupuncture as a complementary therapy to the pharmacological treatment of osteoarthritis of the knee: randomised controlled trial. Full Text available with Trip Pro

Acupuncture as a complementary therapy to the pharmacological treatment of osteoarthritis of the knee: randomised controlled trial. To analyse the efficacy of acupuncture as a complementary therapy to the pharmacological treatment of osteoarthritis of the knee, with respect to pain relief, reduction of stiffness, and increased physical function during treatment; modifications in the consumption of diclofenac during treatment; and changes in the patient's quality of life.Randomised, controlled (...) , single blind trial, with blinded evaluation and statistical analysis of results.Pain management unit in a public primary care centre in southern Spain, over a period of two years.97 outpatients presenting with osteoarthritis of the knee.Patients were randomly separated into two groups, one receiving acupuncture plus diclofenac (n = 48) and the other placebo acupuncture plus diclofenac (n = 49).The clinical variables examined included intensity of pain as measured by a visual analogue scale; pain

2004 BMJ Controlled trial quality: predicted high

500. Randomised controlled trial of magnetic bracelets for relieving pain in osteoarthritis of the hip and knee. Full Text available with Trip Pro

Randomised controlled trial of magnetic bracelets for relieving pain in osteoarthritis of the hip and knee. To determine the effectiveness of commercially available magnetic bracelets for pain control in osteoarthritis of the hip and knee.Randomised, placebo controlled trial with three parallel groups.Five rural general practices.194 men and women aged 45-80 years with osteoarthritis of the hip or knee.Wearing a standard strength static bipolar magnetic bracelet, a weak magnetic bracelet (...) , or a non-magnetic (dummy) bracelet for 12 weeks.Change in the Western Ontario and McMaster Universities osteoarthritis lower limb pain scale (WOMAC A) after 12 weeks, with the primary comparison between the standard and dummy groups. Secondary outcomes included changes in WOMAC B and C scales and a visual analogue scale for pain.Mean pain scores were reduced more in the standard magnet group than in the dummy group (mean difference 1.3 points, 95% confidence interval 0.05 to 2.55). Self reported

2004 BMJ Controlled trial quality: predicted high